Zeitschrift für Parasitenkunde

, Volume 69, Issue 4, pp 415–424 | Cite as

Liposomal chemotherapy in visceral leishmaniasis: An ultrastructural study of an intracellular pathway

  • John S. Weldon
  • John F. Munnell
  • William L. Hanson
  • Carl R. Alving
Original Investigations


The intracellular fate of liposomes administered intracardially was examined in the liver and spleen of hamsters experimentally infected withLeishmania donovani. Separate groups of animals were treated with liposomes containing either an antileishmanial agent, a colloidal gold marker, or saline. Ultrastructural examinations of lysosomal interactions with the parasitophorous vacuole and with phagocytized liposomes were made. Lysosomes readily fused with the parasitophorous vacuoles but appeared to have little effect on the parasite, possibly due to the production of enzyme inhibitors. Liposomes rapidly became localized in lysosomes subsequent to endocytosis by macrophages. Morphologic evidence suggested that secondary lysosomes containing liposomal residues then fused with the parasitophorous vacuole. Aspects of one possible pathway are discussed which may account for the greatly enhanced effectiveness of liposomal chemotherapy for experimental visceral leishmaniasis.


Gold Enzyme Inhibitor Separate Group Visceral Leishmaniasis Leishmaniasis 
These keywords were added by machine and not by the authors. This process is experimental and the keywords may be updated as the learning algorithm improves.


Unable to display preview. Download preview PDF.

Unable to display preview. Download preview PDF.


  1. Alexander J, Vickerman K (1975) Fusion of host cell lysosomes with parasitophorous vacuoles ofLeishmania mexicana-infected macrophages. J Protozool 22:502–508PubMedGoogle Scholar
  2. Alving CR, Steck EA (1979) The use of liposome-encapsulated drugs in leishmaniasis. Trends Biochem Sci 4:N175-N177Google Scholar
  3. Alving CR, Steck EA, Chapman WL Jr, Waits VB, Hendricks LD, Swartz GM, Hanson WL (1978a) Therapy of leishmaniasis: superior efficacies of liposome-encapsulated drugs. Proc Natl Acad Sci USA 75:2959–2963PubMedGoogle Scholar
  4. Alving CR, Steck EA, Hanson WL, Loizeaux PS, Chapman WL Jr, Waits VB (1978b) Improved therapy of experimental leishmaniasis by use of a liposome-encapsulated antimonial drug. Life Sci 22:1021–1026PubMedGoogle Scholar
  5. Alving CR, Steck EA, Chapman WL Jr, Waits VB, Hendricks LD, Swartz GM Jr, Hanson WL (1980) Liposomes in leishmaniasis: Therapeutic effects of antimonial drugs, 8-aminoquinolines and tetracycline. Life Sci 26:2231–2238PubMedGoogle Scholar
  6. Barsy T de, Devos P, Van Hoof F (1976) A morphologic and biochemical study of the fate of antibody-bearing liposomes. Lab Invest 34:273–282PubMedGoogle Scholar
  7. Black CDV, Watson GJ, Ward RJ (1977) The use of Pentostam liposomes in the chemotherapy of experimental leishmaniasis. Trans R Soc Trop Med Hyg 71:550–552PubMedGoogle Scholar
  8. Chang KP, Dwyer DM (1976)Leishmania donovani, hamster macrophage interactions in vitro: cell entry, intracellular survival and multiplication of amastigotes. J Exp Med 147:515–530Google Scholar
  9. Etherton JE, Botham CM (1970) Factors affecting lead capture methods for the fine localization of rat lung acid phosphatase. Histochem J 2:507–519PubMedGoogle Scholar
  10. Fahman Y, Wright BJ (1975) Liposomes containing chelating agents. Cellular penetration and a possible mechanism of metal removal. J Cell Biol 65:112–122PubMedGoogle Scholar
  11. Hanson WL, Chapman WL Jr, Kinnamon KE (1977) Testing of drugs for antileishmanial activity in golden hamsters infected withLeishmania donovani. International J Parasit 7:443–447Google Scholar
  12. Hesketh TR, Payne SN, Humphrey JH (1972) Complement and phospholipase C lysis of lipid membranes. Immunol 23:705–771Google Scholar
  13. Ionue K, Kinsky SC (1970) Fate of phospholipids in liposomal model membranes damaged by antibody and complement. Biochemistry 9:4767–4776PubMedGoogle Scholar
  14. Lewis DH, Peters W (1977) The resistance ofLeishmania parasites to digestion by lysosomal enzymes. Ann Trop Med Parasit 71:295–312PubMedGoogle Scholar
  15. Mahmoud AAF, Warren KS (1977) Algorithms in the diagnosis and management of exotic diseases. XXIV Leishmaniases J Infect Dis 136:160–163Google Scholar
  16. Mattenberger-Kreber L, Auderset G, Schneider M, Louis-Broillet A, Benedetti MS, Malnoe A (1976) Phagocytose des liposomes par les macrophages peritoneaux. Experentia 32:1522–1524Google Scholar
  17. New RRC, Chance JL, Thomas SC, Peters W (1978) Antileishmanial activity of antimonials entrapped in liposomes. Nature 272:55–56PubMedGoogle Scholar
  18. Roelofsen B, Zwall RFA, Comfuris P, Woodward DB, Deenen LLM van (1971) Action of pure phospholipase A2 and phospholipase C on human erythrocytes and ghosts. Biochem Biophys Acta 241:925–929PubMedGoogle Scholar
  19. Segal AW, Willis EJ, Richmond JE, Slavin G, Black DCV, Gregoriadis G (1974) Morphological observations on the cellular and subcellular destination of intravenously administered liposomes. Br J Exp Pathol 55:320–327PubMedGoogle Scholar
  20. Singleton WS, Gray MS, Brown ML, White JL (1965) Chromatographically homogeneous lecithin from egg phospholipids. J Amer Oil Chem Soc 42:53–56Google Scholar
  21. Spurr AR (1969) A low viscosity resin embedding media for electron microscopy. J Ultrastruct Res 26:31–43PubMedGoogle Scholar

Copyright information

© Springer-Verlag 1983

Authors and Affiliations

  • John S. Weldon
    • 1
  • John F. Munnell
    • 1
  • William L. Hanson
    • 2
  • Carl R. Alving
    • 3
  1. 1.Department of Anatomy and RadiologyUniversity of GeorgiaAthensUSA
  2. 2.Department of Parasitology; College of Veterinary MedicineUniversity of GeorgiaAthensUSA
  3. 3.Department of Membrane BiochemistryWalter Reed Army Institute of ResearchWashington, DCUSA

Personalised recommendations